NCT03286166撤回不适用
A Randomized Controlled Trial to Evaluate the Efficiency of Serum Tears Made With Genius PRP for Improving Signs and Symptoms in Dry Eye Disease (DED)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Toyos Clinic
- 试验地点
- 1
- 主要终点
- The difference in the change of EDS score from baseline and the tear breakup time from baseline to follow-up, between study eyes in the study arm and study eyes in the control arm
研究概览
简要总结
A randomized controlled trial to evaluate the efficiency of serum tears made with Genius PRP for improving signs and symptoms in Dry Eye Disease (DED).
Single center, Prospective, Randomized, Controlled, Non-significant risk
详细描述
Genius PRP is a class II medical device with an 510(k)FDA clearance for platelet and plasma separation for bone graft handling.
Subjects will sign the IC form within one week of being having been provided the form, at which time they will undergo the following assessments:
- Routine ophthalmology tests (biomicroscopy, BCVA and IOP) including corneal fluorescein staining and lissamine green conjunctival staining
- Measurement of tear break up time (TBUT) in both eyes. These values will be used as baseline.
- Self-administration of the Eye Dryness Scale; 0-100 visual analogue scale. This score will be used as baseline.
- Self-administration of Visual Analog Pain Scale
- Eligible subjects will be randomized with right eye to receive PRP and left eye to receive vehicle eye drops in the same dosage.
Outcome measures will be assessed in both eyes.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 22 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Able to read, understand and sign an Informed Consent (IC) form 2) 22-85 years of age 3) Able and willing to comply with the treatment/follow-up schedule and requirements 4) Tear break up time of less than 10 seconds in both eyes 5) SPK in the conjunctiva and/or cornea of each eye 6) Eye dryness scale of 40 or greater at baseline for each eye 7) Self- reported ocular pain from dry eye disease
排除标准
- •Unwilling to discontinue use of contact lenses for the duration of the study 2) Ocular surgery or eyelid surgery, within 3 months prior to screening 3) Neuro-paralysis in the planned treatment area, within 6 months prior to screening 4) Other uncontrolled eye disorders affecting the ocular surface, for example active allergies 5) Punctal plugs placed within past 90 days 6) Pre-cancerous lesions, skin cancer or pigmented lesions in the planned treatment area 7) Uncontrolled infections or uncontrolled immunosuppressive diseases 8) Subjects with current ocular infections. 9) New prescription eye drops for dry eye or glaucoma or omega 3 supplements prescribed within 90 days prior to screening, excluding artificial tears 10) New topical treatments within the area to be treated, or oral therapies, within 3 months prior to screening- except over-the-counter acetaminophen-based analgesics for pain management 11) Change in dosage of any systemic medication, within 3 months prior to screening 12) Anticipated relocation or extensive travel outside of the local study area preventing compliance with follow-up over the study period 13) Legally blind in one or both eyes 14) First IPL treatment, within 3 months prior to screening 15) Any condition revealed during the eligibility screening process whereby the investigator deems the subject inappropriate for this study
结局指标
主要结局
The difference in the change of EDS score from baseline and the tear breakup time from baseline to follow-up, between study eyes in the study arm and study eyes in the control arm
时间窗: 3 months
* Change in EDS questionnaire from baseline * Change in TBUT from baseline.
次要结局
- The improvement of signs and visual analog pain scale in the study group is larger than the improvement of signs in the control group(3 months)
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.Erectile Dysfunction Following Radiation TherapyPhosphodiesterase Inhibitor Adverse ReactionPlatelet- Rich Plasma (PRP)NCT05787769Mansoura University96
Unknown
不适用
Effectiveness of Platelet-rich Plasma for Treatment of Trigger FingerTendon EntrapmentNCT04167098Töölö Hospital117
已完成
不适用
A randomised controlled trial for the effect of preoperative physiotherapy in patients with an increased risk for the development of postoperative pulmonary complications after open-heart surgeryPostoperative pulmonary complicationsSurgeryISRCTN17691887The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)600
已完成
2 期
Erythropoietin Therapy for Children With Cerebral PalsyCerebral PalsyNCT01650415Bundang CHA Hospital11
已完成
不适用
Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint PainJoint PainNCT05052112Vedic Lifesciences Pvt. Ltd.40